References
- Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;2:CD000510 . DOI: 10.1002/14651858.CD000510
- Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000;4:CD001456 . DOI: 10.1002/14651858.CD001456
- Dani C, Corsini I, Bertini G, et al. The INSURE method in preterm infants of less than 30 weeks' gestation. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2010, 23:1024–9
- Finer NN, Carlo WA, Duara S, et al. Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 2004;114:651–7
- Halliday HL. Recent clinical trials of surfactant treatment for neonates. Biol Neonate 2006;89:323–9
- Ammari A, Suri M, Milisavljevic V, et al. Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 2005;147:341–7
- Vanpee M, Walfridsson-Schultz U, Katz-Salamon M, et al. Resuscitation and ventilation strategies for extremely preterm infants: a comparison study between two neonatal centers in Boston and Stockholm. Acta Paediatr 2007;96:10–16 ; discussion 18–19
- Gittermann MK, Fusch C, Gittermann AR, et al. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants. Eur J Pediatr 1997;156:384–8
- Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700–8
- Finer NN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970–9
- Sweet DG, Halliday HL. The use of surfactants in 2009. Arch Dis Child Educ Pract Ed 2009;94:78–83
- Engle WA. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008;121:419–32
- Gortner L, Misselwitz B, Milligan D, et al. Rates of Bronchopulmonary Dysplasia in Very Preterm Neonates in Europe: results from the MOSAIC Cohort. Neonatology 2010;99:112–17
- Verder H. Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatr 2007;96:482–4
- Been JV, Rours IG, Kornelisse RF, et al. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr 2010;156:10–15 e11
- Perrone S, Toti P, Toti MS, et al. Perinatal outcome and placental histological characteristics: a single-center study. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet 2012;25:110–13
- Perlman JM. The relationship between systemic hemodynamic perturbations and periventricular-intraventricular hemorrhage–a historical perspective. Semin Pediatr Neurol 2009;16:191–9
- Soll R, Ozek E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2010;1:CD001079 . DOI: 10.1002/14651858.CD001079.pub2
- Hill A, Melson GL, Clark HB, Volpe JJ. Hemorrhagic periventricular leukomalacia: diagnosis by real time ultrasound and correlation with autopsy findings. Pediatrics 1982;69:282–4
- Mehrabani D, Gowen CW Jr, Kopelman AE. Association of pneumothorax and hypotension with intraventricular haemorrhage. Arch Dis Child 1991;66:48–51
- Hill A, Perlman JM, Volpe JJ. Relationship of pneumothorax to occurrence of intraventricular hemorrhage in the premature newborn. Pediatrics 1982;69:144–9
- Lipscomb AP, Thorburn RJ, Reynolds EO, et al. Pneumothorax and cerebral haemorrhage in preterm infants. Lancet 1981;1:414–16